filmov
tv
Dr. Daver on Results of a Combination Study With Azacitidine/Nivolumab in AML
Показать описание
Naval G. Daver, MD, associate professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center, discusses the results of a phase Ib/II study that evaluated the combination of azacitidine and nivolumab (Opdivo) in patients with relapsed/refractory acute myeloid leukemia.
0:01:53
0:00:25
0:01:08
0:01:19
0:02:02
0:02:18
0:01:09
0:04:35
0:05:25
0:09:55
0:05:30
0:05:17
0:05:59
0:06:24
0:04:20
0:06:44
1:42:07
0:03:59
0:01:42
0:05:10
0:16:47
0:08:13
0:25:26